Navigation Links
PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL
Date:5/30/2008

Panel Votes, 16-0, in Favor of Short-Term Treatment of Chronic Idiopathic Thrombocytopenic Purpura (ITP)

CHICAGO, May 30 /PRNewswire-USNewswire/ -- GlaxoSmithKline (NYSE: GSK) today announced that the United States Food and Drug Administration's Oncology Drugs Advisory Committee (ODAC) unanimously voted, 16-0, that PROMACTA(R) (eltrombopag) demonstrated a favorable risk-benefit profile for the short-term treatment of patients with chronic idiopathic thrombocytopenic purpura (ITP). The FDA advisory committee was held onsite at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting.

The advisory committee reviewed studies evaluating the safety and efficacy of eltrombopag in the short-term setting. Clinical data were presented and discussed that support eltrombopag increased platelet counts and reduced bleeding.

"Chronic ITP is a condition, which can have serious complications and be life threatening. Two of the most fundamental endpoints are crucial to managing this disease -- improved platelet counts and decreased bleeding. If approved, this would make the drug a potential new clinical option that can address a true unmet medical need," said Paolo Paoletti, M.D., Senior Vice President of the Oncology Medicine Development Center at GSK. "An FDA approval for eltrombopag would represent an important development for these patients and would make the medication the first oral treatment of its kind for this disease. We look forward to working with the agency to achieve that goal."

In addition to today's recommendation, the FDA recently granted eltrombopag orphan drug designation for this indication. Orphan designation is a special status the FDA grants to products that treat a rare disease or conditio
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... (PRWEB) July 24, 2014 Dr. Alicia ... University (CCSU), is conducting two studies to determine the ... is particularly vulnerable to the introduction of disease-carrying mosquitoes ... ports, and centers of international travel. However, it is ... and how common they are. , Is that ...
(Date:7/24/2014)... July 24, 2014 Crawford Technologies ... conducted in partnership with AIIM, focusing on global ... surprising insight of the survey indicated that even ... customer correspondence for customer service, legal and regulatory ... of organizations save exact facsimiles of these documents. ...
(Date:7/24/2014)... After waiting two years for her agonizing ... Ackerman decided it was time to get her life back ... a surgical intervention was needed to bring her true relief. ... Spine Surgery Center for help. Each staff member involved in ... living in Montana, the connection and security this Florida team ...
(Date:7/24/2014)... GILBERT, AZ (PRWEB) July 24, 2014 ... respected global consumer brands: SweetLeaf Stevia® Sweetener and Wisdom ... key executives responsible for implementing innovative, high growth strategies. ... announced the expansion of the executive leadership team today. ... team to lead our brands into the future. The ...
(Date:7/24/2014)... 24, 2014 Professional Healthcare at Home, an ... Karen Schulkin, a nurse with the company’s Pleasant Hill, CA, ... Finalist for the 2014 Home Care & Hospice Nurse of ... Care & Hospice (NAHC). , Annually, NAHC promotes a ... public to help choose a top home care and hospice ...
Breaking Medicine News(10 mins):Health News:Connecticut Professor Studies Prevalence of Mosquitoes Species That Can Carry Deadly EEEV & West Nile Virus 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4Health News:Wisdom Natural Brands Announces Key Executive Management Team 2Health News:Wisdom Natural Brands Announces Key Executive Management Team 3Health News:Wisdom Natural Brands Announces Key Executive Management Team 4Health News:Wisdom Natural Brands Announces Key Executive Management Team 5Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 2Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 3
... SCOTTSDALE, Ariz., July 9 Four out of 10 adults who ... of children who stutter have been bullied or teased, according to ... make up about 1 percent of the population. , ... national conference in Scottsdale, AZ. , , While there ...
... D. Smith recently announced the promotions of Jeff Greer to ... vice president of purchasing and trade relations. These appointments ... senior leadership to maximize growth potential. , ... Company,s sales efforts to expand into new service sectors. ...
... ongoing recession and associated job cuts is creating a ... slowing health insurer growth and pressuring profitability, according to ... , "Conning projects that health care costs will ... margins through 2011," said Terence Martin, analyst at Conning ...
... 2009 As soccer continues to grow in popularity, injuries ... Certain injuries fall into gender-based patterns and new ... causes that could help lead to better treatment, or ... Data presented at this year,s American Orthopaedic Society for ...
... MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced ... license agreement with AstraZeneca related to the company,s Unit Dose ... July 8, 2009, effective immediately. All rights licensed to ... MAP Pharmaceuticals plans to suspend development of UDB, which did ...
... and HAMILTON, New Zealand, July 9 ZyGEM Corp. ... extraction and other life sciences applications, today announced the ... prep GEM(R) Bacteria DNA extraction kit is capable ... range of bacterial species, including mixed or unknown sample ...
Cached Medicine News:Health News:Survey: Speech Therapy Helps, But People Who Stutter Suffer Discrimination 2Health News:H. D. Smith Promotes Leadership to Fill Two Senior Roles 2Health News:Conning Research: Health Insurance Industry Premium Growth and Profitability Under Pressure Through 2011 2Health News:Motion analysis helps soccer players get their kicks 2Health News:Motion analysis helps soccer players get their kicks 3Health News:MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration 2Health News:MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration 3Health News:ZyGEM Releases Data Confirming Its prepGEM(R) Bacteria Kit Is a Simple, Universal Method for Extracting DNA from Different Bacteria Species 2Health News:ZyGEM Releases Data Confirming Its prepGEM(R) Bacteria Kit Is a Simple, Universal Method for Extracting DNA from Different Bacteria Species 3Health News:ZyGEM Releases Data Confirming Its prepGEM(R) Bacteria Kit Is a Simple, Universal Method for Extracting DNA from Different Bacteria Species 4
(Date:7/24/2014)... N.J. , July 24, 2014 /PRNewswire/ ... CTSH ) today announced that it has ... , a non-profit organization with membership representation ... a first-of-its-kind, subscription-based platform that will transform ... companies on clinical trials. TransCelerate BioPharma Inc. ...
(Date:7/23/2014)... 2014  Varian Medical Systems (NYSE: VAR ... diluted share in the third quarter of fiscal year ... per diluted share due to an approximately $8 million ... equity investment in Augmenix, a privately-held company developing minimally ... million for the third quarter of fiscal year 2014, ...
(Date:7/23/2014)... DUBLIN , July 23, 2014 ... "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & ... report to their offering. ... market is segmented into three major segments, namely, holter ... overall market was valued at $3,683 million in 2013 ...
Breaking Medicine Technology:TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 2TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 3TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 4TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3
... Cayenne Medical, Inc., a private sports medicine device ... that effective immediately, David B. Springer will succeed James ... transitioned to Executive Chairman due to health reasons. ... President and CEO since the company,s inception in 2005, ...
... ACCESS PHARMACEUTICALS, INC. ... a biopharmaceutical company leveraging its proprietary drug-delivery platforms to ... and diabetes, reported it has been receiving ... MuGard for patients undergoing radiation and chemotherapy for various ...
Cached Medicine Technology:Cayenne Medical, Inc. Appoints David B. Springer President & CEO 2Cayenne Medical, Inc. Appoints David B. Springer President & CEO 3Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential 2Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential 3Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential 4
... Random Dot Stereo Depth Perception for ... of arc) and Fine Depth,Perception. , ... (800 to 40 sec of arc), ... to 100 sec of arc), 1 ...
Our high quality therapeutic drug monitoring reagents, calibrators and controls are available for most chemistry analyzers. Reproducible and accurate results for your laboratory needs....
The Emit 2000 Phenytoin Assay is a homogeneous enzyme immunoassay for use in the quantitative analysis of phenytoin in human serum or plasma. Kits are conveniently packaged in Olympus Reagent Cartrid...
... Digoxin Assay is a homogeneous ... in the quantitative analysis of ... plasma. Kits are packaged specifically ... COBAS MIRA, COBAS MIRA S, ...
Medicine Products: